BayWas, Restructuring

BayWa's Restructuring Hinges on April Cash and Legal Minefield

22.04.2026 - 07:24:07 | boerse-global.de

German agri-trader BayWa faces a critical April payment and a bank decision that could collapse its rescue, amid lawsuits and a €132M write-down by its cooperative bank owners.

BayWa's Restructuring Hinges on April Cash and Legal Minefield - Foto: über boerse-global.de
BayWa's Restructuring Hinges on April Cash and Legal Minefield - Foto: über boerse-global.de

The fate of German agricultural trader BayWa is set to be determined in the coming weeks, with a critical €45 million payment due in April and a looming bank decision that could unravel its entire rescue plan. The company's shares, trading at €13.40, have fallen 20% since the start of the year, including a 7.6% drop in a single day, reflecting the intense pressure.

At the heart of the crisis is a structural conflict. BayWa's primary owners, a group of Bavarian cooperative banks, are also its largest creditors, bearing the restructuring risk on both sides of the balance sheet. They have already absorbed significant pain, writing down 60% of a €220 million promissory note in their 2024 accounts—a €132 million loss. Stefan Müller, president of the cooperative association, has acknowledged that further write-downs have been recommended, with a worst-case scenario involving a complete write-off of additional promissory notes in the triple-digit millions.

The immediate trigger for the latest sell-off is a wave of legal threats. Law firm TILP is preparing mass lawsuits for all investors who purchased BayWa shares between January 2022 and January 2026. This follows a rebuke from German financial watchdog BaFin, which criticized BayWa for omitting crucial details about a billion-euro loan and refinancing risks for a €500 million bond in its 2023 annual report.

Parallel investigations by the Munich I public prosecutor's office are examining former CEOs, including Klaus Josef Lutz and Marcus Pöllinger, on suspicion of breach of trust and the deliberate misrepresentation of liquidity risks. All accused are presumed innocent. Auditor PwC is also under scrutiny, with the audit oversight body Apas initiating proceedings after it issued an unqualified audit opinion for 2023 without highlighting existential threats. BayWa will put its auditing mandate out to tender after 2026 and is examining damage claims against its former auditors.

Should investors sell immediately? Or is it worth buying BayWa?

This legal quagmire creates a critical information vacuum. The audited group financial statements for 2025 are not expected until the fourth quarter of 2026. Until then, investors and banks are operating without certified numbers, making any fundamental assessment nearly impossible.

Against this uncertainty, the company's survival hinges on two near-term events. The €45 million from the sale of its Cefetra unit, expected in April, must arrive on time. This will be supplemented by roughly €62 million from the repayment of shareholder loans. The divestment is designed to reduce group bank debt by over €600 million and strengthen BayWa's hand in negotiations.

The real deadline, however, is set by lenders DZ Bank and HVB. They must decide whether to extend a standstill agreement until autumn 2026. If they refuse, the StaRUG restructuring plan finalized in May 2025 loses its legal foundation, causing the entire current concept to fail. The incoming cash is meant to pressure the banks into an extension.

Longer-term asset sales are proving challenging. The planned partial sale of the renewable energy unit BayWa r.e. has effectively failed, with the loss of U.S. subsidies in early 2025 depressing achievable prices. The company now expects only €150 million in EBITDA from the division by 2030, down from a previous target of €230 million for 2028.

Goldman Sachs has been seeking a buyer for BayWa's roughly 74% stake in New Zealand fruit producer T&G Global since March. T&G, which markets apple brands like Envy and Jazz in over 60 countries and posted $1.3 billion in revenue in 2024, returned to profitability. The process is complicated by Hong Kong-based minority shareholder Joy Wing Mau Group, which holds nearly 20%. Even if successful, the expected proceeds of around €300 million will barely make a dent in the multi-billion euro financing gap.

BayWa at a turning point? This analysis reveals what investors need to know now.

Internally, the board has scrapped its 2026 forecast and lowered its adjusted EBITDA target for 2027 to around €140 million. The supervisory council has tightened controls, lowering the threshold for board transactions requiring approval from €200 million to €50 million. The overarching plan is to shrink the group to four core business areas by the end of 2028, cutting around 1,300 jobs and reducing revenue to approximately €10 billion.

With annualized share price volatility near 50%, BayWa embodies a high-risk restructuring process defined by dependencies and a lack of security. Two outcomes will ultimately chart its course: a final agreement with the banks and the delivery of audited financials. Both are not expected before the final quarter of 2026, leaving shareholders in a prolonged state of suspense.

Ad

BayWa Stock: New Analysis - 22 April

Fresh BayWa information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated BayWa analysis...

So schätzen die Börsenprofis BayWas Aktien ein!

<b>So schätzen die Börsenprofis BayWas Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | DE0005194005 | BAYWAS | boerse | 69233590 |